Injectable Drug Compatibility News
Summer 2018 IV Compatibility & Stability
In this supplement we added a new drug monograph for PLERIXAFOR with new stability and compatibility information. We added new stability information for the existing drug monographs for DECITABINE MESYLATE, EPINEPHRINE HYDROCHLORIDE, MEROPENEM AND VABORBACTAM, NOREPINEPHRINE BITARTRATE, OXALIPLATIN, ROLAPITANT HYDROCHLORIDE, and VALPROATE SODIUM. In addition, new compatibility information is reported for these existing monographs: BACLOFEN, DEXAMETHASONE SODIUM PHOSPHATE, MORPHINE SULFATE, PALONOSETRON HYDROCHLORIDE, ROLAPITANT HYDROCHLORIDE, and MEROPENEM AND VABORBACTAM with 88 different drugs.
Spring 2018 IV Drug Compatibility & Stability
In this supplement we added a new drug monograph for ROLAPITANT HYDROCHLORIDE and provided new stability and compatibility information. We added new stability information for the existing drug monographs for AZACITIDINE, BUSULFAN, DALTEPARIN SODIUM, DEXMEDETOMIDINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, and PROCAINAMIDE HYDROCHLORIDE. In addition, new compatibility information is reported for these existing monographs: DEXAMETHASONE SODIUM PHOSPHATE, GENTAMICIN SULFATE, GRANISETRON HYDROCHLORIDE, HEPARIN SODIUM, PALONOSETRON HYDROCHLORIDE, SODIUM CITRATE, VANCOMYCIN; and BLINATUMOMAB with 39 other drugs.
Without King Guide You Are Missing New Information
In 2017 we added 17 new injectable drugs, new compatibility information for 263 drugs, and new stability information for 44 drugs. IV compatibility modules included in other products do not specify what is included in their updates, and are prepared by staff pharmacists. At King Guide, we list every drug that is updated each quarter on our website so you can be aware of new and updated information and our editor is the only remaining authority that has done this work exclusively for the last 25 years.
Winter 2017 Update
In this supplement we added new stability information for the existing drug monograph for TENECTEPLASE. In addition, new compatibility information is reported for these existing monographs: MORPHINE SULFATE, ROPIVACAINE HYDROCHLORIDE, and ZICONOTIDE; COLISTIMETHATE SODIUM WITH ERTAPENEM, IMIPENEM-CILASTATIN SODIUM, LINEZOLID, MEROPENEM, PIPERACILLIN AND TAZOBACTAM, and VANCOMYCIN HYDROCHLORIDE; and ISAVUCONAZONIUM SULFATE with 95 other drugs.
Fall 2017 Update
In this supplement we added new stability information for these existing drug monographs: ALPROSTADIL, METHOTREXATE, and SILDENAFIL CITRATE. In addition, new compatibility information is reported for over 100 existing drug monographs, including entries for CEFTOLOZANE and TAZOBACTAM with 95 other drugs, CEFTAZIDIME AND AVIBACTAM, DOPAMINE HYDROCHLORIDE, HEPARIN SODIUM, PIPERACILLIN AND TAZOBACTAM, SILDENAFIL CITRATE, and VANCOMYCIN HYDROCHLORIDE.